Financial News · Live Terminal

Page 447 of 540

KeyBanc Adjusts Price Target on Robinhood Markets to $100 From $110, Maintains Overweight Rating

Robinhood Markets (HOOD) has an average rating of overweight and mean price target of $102.46, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $72.21, Change: $-9.86, Percent Change: -12.01%

$HOOD

Wire104d ago

Wedbush Raises Price Target on SanDisk to $1,200 From $740, Keeps Outperform Rating

SanDisk (SNDK) has an average rating of overweight and mean price target of $1,015.95 according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)Price: $1071.65, Change: $+69.30, Percent Change: +6.91%

$SNDK

Wire104d ago

Avis Budget Group's Q1 Loss Narrows, Revenue Rises; Shares Fall Pre-Bell

Avis Budget Group (CAR) reported a Q1 loss Wednesday of $8.01 per diluted share, compared with a loss of $14.35 a year earlier.Analysts surveyed by FactSet expected a loss of $7.29.Revenue for the quarter ended March 31 was $2.53 billion, compared with $2.43 billion a year earlier.Analysts surveyed by FactSet expected $2.43 billion.Shares of Avis fell more than 15% in recent premarket activity Wednesday.Price: $153.00, Change: $-29.01, Percent Change: -15.94%

$CAR

Wire104d ago

Verisk Analytics Q1 Adjusted Earnings, Revenue Rise; 2026 Outlook Affirmed

Verisk Analytics (VRSK) reported Q1 adjusted earnings Wednesday of $1.82 per diluted share, up from $1.73 a year earlier.Analysts surveyed by FactSet expected $1.74.Revenue for the quarter ended March 31 was $782.6 million, compared with $753 million a year earlier.Analysts surveyed by FactSet expected $771.6 million.For 2026, the company reaffirmed its adjusted EPS guidance of $7.45 to $7.75. Analysts surveyed by FactSet expect $7.62.Revenue for the year is still projected to be $3.19 billion to $3.24 billion. Analysts surveyed by FactSet expect $3.21 billion.Shares of the company rose more than 3% pre-bell Wednesday.Price: $182.00, Change: $+5.34, Percent Change: +3.02%

$VRSK

Wire104d ago

GE Healthcare Technologies Q1 Adjusted Earnings Fall, Revenue Rises; Lowers 2026 Adjusted EPS Guidance -- Shares Down Pre-Bell

GE Healthcare Technologies (GEHC) reported Q1 adjusted earnings Wednesday of $0.99 per diluted share, down from $1.01 a year earlier.Analysts polled by FactSet expected $1.05.Revenue for the quarter ended March 31 was $5.13 billion, compared with $4.78 billion a year earlier.Analysts surveyed by FactSet expected $5.03 billion.For 2026, the company now expects adjusted EPS of $4.80 to $5, compared with its prior guidance of $4.95 to $5.15. Analysts polled by FactSet expect $5.06.Meanwhile, GE Healthcare reiterated its full-year guidance of 3% to 4% organic revenue growth. Analysts polled by FactSet expect $21.71 billion.Shares of the company were down over 6% in Wednesday premarket activity.Price: $64.12, Change: $-4.38, Percent Change: -6.39%

$GEHC

Wire104d ago

Update: Seagate Technology Fiscal Q3 Earnings, Sales Jump; Q4 Outlook Beats; Shares Soar Premarket

(Updates with the stock move in the headline and the first paragraph)Seagate Technology (STX) shares rose over 18% in Wednesday's premarket activity after the company reported overnight stronger-than-expected fiscal Q3 earnings and revenue, as well as guidance for the next quarter that beat estimates.The company reported fiscal Q3 non-GAAP earnings late Tuesday of $4.10 per diluted share, up from $1.90 a year earlier.Analysts polled by FactSet expected $3.51.Revenue for the quarter that ended April 3 was $3.11 billion, up from $2.16 billion a year earlier.Analysts surveyed by FactSet expected $2.96 billion.The company said it expects fiscal Q4 non-GAAP EPS of $5.00, plus or minus $0.20. Analysts expect $3.99.Fiscal Q4 revenue is estimated to be $3.45 billion, plus or minus $100 million. Analysts expect $3.16 billion.Price: $683.94, Change: $+104.91, Percent Change: +18.12%

$STX

Wire104d ago

Brown-Forman, Pernod Ricard End Talks on Potential Combination

Brown-Forman (BF.A) and Pernod Ricard ended discussions over a potential business combination after failing to reach mutually agreeable terms."We intend to create long-term value for all stakeholders by focusing on our strategic and operational priorities," Brown-Forman said Tuesday in a statement. "This includes unlocking future growth by expanding our geographic footprint, continuing to build brands that resonate with consumers, and enhancing operational efficiency."In late March, the companies confirmed they were in talks, noting "there could be no assurance that any such agreement would be reached."Brown-Forman shares fell 2.9% in after-hours trading.

$BF.A$BF.B

Wire104d ago

Update: Visa Fiscal Q2 Adjusted Earnings, Revenue Rise

(Updates with share repurchase and dividend information in the last two paragraphs.)Visa (V) reported fiscal Q2 adjusted earnings late Tuesday of $3.31 per diluted share, up from $2.76 a year earlier.Analysts polled by FactSet expected $3.10.Revenue for the three months ended March 31 was $11.23 billion, up from $9.59 billion a year earlier.Analysts polled by FactSet expected $10.75 billion.In April, the company's board authorized a new $20 billion multi-year share repurchase program, it said.Visa also maintained its quarterly dividend at $0.67 per share, payable June 1 to holders on record as of May 12.

Wire104d ago

BXP Q1 FFO Falls, Revenue Rises; Shares Drop After Hours

BXP Inc (BXP) reported Q1 funds from operations late Tuesday of $1.59 per diluted share, down from $1.64 a year earlier.Analysts surveyed by FactSet expected $1.58.Revenue in the three months ended March 31 rose to $872.1 million from $865.2 million a year earlier.Analysts polled by FactSet expected $843.1 million.The company expects FFO of $1.69 to $1.71 a share in Q2 and $6.90 to $7.04 a share in the full year, compared with the prior forecast of $6.88 to $7.04.Analysts surveyed by FactSet expect $1.72 in Q2 and $6.95 in the full year.BXP shares fell 4.6% in after-hours trading.

$BXP

Wire104d ago

Element Solutions Q1 Adjusted Earnings, Revenue Rise; Shares Gain After Hours

Element Solutions (ESI) reported Q1 adjusted earnings late Tuesday of $0.41 per diluted share, up from $0.34 a year earlier.Analysts polled by FactSet expected $0.38.Revenue in the three months ended March 31 rose to $840 million from $593.7 million a year earlier.Analysts surveyed by FactSet expected $710.5 million.Element Solutions shares rose 7% in after-hours trading.

$ESI

Wire104d ago

Fair Isaac Fiscal Q2 Adjusted Earnings, Revenue Climb; FY Outlook Raised; Shares Gain After Hours

Fair Isaac (FICO) reported fiscal Q2 adjusted earnings late Tuesday of $12.50 per diluted share, up from $7.81 a year earlier.Analysts polled by FactSet expected $10.89.Revenue in the quarter ended March 31 rose to $691.7 million from $498.7 million a year earlier.Analysts surveyed by FactSet expected $630.2 million.The company raised fiscal 2026 guidance to adjusted EPS of $40.45 on revenue of $2.45 billion, compared with its prior forecast of EPS of $38.17 on revenue of $2.35 billion.Fair Isaac shares rose 5.9% in after-hours trading.

$FICO

Wire104d ago

Seagate Technology Fiscal Q3 Non-GAAP Earnings, Revenue Rise; Q4 Guidance Set

Seagate Technology (STX) reported fiscal Q3 non-GAAP earnings late Tuesday of $4.10 per diluted share, up from $1.90 a year earlier.Analysts polled by FactSet expected $3.51.Revenue for the quarter that ended April 3 was $3.11 billion, up from $2.16 billion a year earlier.Analysts surveyed by FactSet expected $2.96 billion.The company said it expects fiscal Q4 non-GAAP EPS of $5.00, plus or minus $0.20. Analysts expect $3.99.Fiscal Q4 revenue is estimated to be $3.45 billion, plus or minus $100 million. Analysts expect $3.16 billion.Shares of the company were up 12% in after-hours trading.

$STX

Wire104d ago

Omnicom Group Q1 Non-GAAP Net Income, Revenue Rise

Omnicom Group (OMC) reported Q1 non-GAAP net income late Tuesday of $1.90 per diluted share, up from $1.70 a year earlier.Analysts polled by FactSet expected $1.82.Revenue for the quarter ended March 31 rose to $6.24 billion from $3.69 billion a year earlier.Analysts surveyed by FactSet expected $5.85 billion.Omnicom shares fell 1.7% in after-hours trading.

$OMC

Wire104d ago

Visa Fiscal Q2 Adjusted Earnings, Revenue Rise

Visa (V) reported fiscal Q2 adjusted earnings late Tuesday of $3.31 per diluted share, up from $2.76 a year earlier.Analysts polled by FactSet expected $3.10.Revenue for the three months ended March 31 was $11.23 billion, up from $9.59 billion a year earlier.Analysts polled by FactSet expected $10.75 billion.

Wire104d ago

Booking Q1 Adjusted Earnings, Revenue Rise

Booking (BKNG) reported Q1 adjusted earnings late Tuesday of $1.14 per diluted share, up from $0.99 a year earlier.Analysts polled by FactSet expected $1.08.Revenue for the three months ended March 31 was $5.53 billion, up from $4.76 billion a year earlier.Analysts surveyed by FactSet expected $5.52 billion.For Q2, the company expects revenue growth rate of 4% to 6%. For the full year 2026, the company expects low-to mid-teens adjusted EPS growth on high-single digit revenue growth.

$BKNG

Wire104d ago

Earnings Flash (V) Visa Posts Fiscal Q2 Revenue $11.2B, vs. FactSet Est of $10.75B

Wire104d ago

Top Cryptocurrencies Mixed; Bitcoin Holds Above $76,000 Level

Major digital assets were mixed Tuesday, with Bitcoin (BTC-USD) lower but holding above the $76,000 level.The CoinDesk Market Index, which tracks dozens of digital assets including Bitcoin, fell almost 0.3% in the past 24 hours. The Nasdaq 100 decreased 1%, the S&P 500 fell 0.5%, and the Dow Jones Industrial Average was down 0.1%.Bitcoin fell 0.7% to $76,316, according to CoinMarketCap data. The most popular cryptocurrency's 24-hour trading volume declined 18.3% to $32.51 billion.Ethereum (ETH-USD), the second-largest digital asset by market value, added 0.7% to $2,302.XRP (XRP-USD) dropped 0.5%, BNB (BNB-USD) rose 0.1%, and Solana (SOL-USD) fell 0.3%. Dogecoin (DOGE-USD) gained 2%, while Cardano (ADA-USD) added 0.8%.The US 10-year Treasury yield stood at 4.351% at 3 p.m. ET Tuesday, up from 4.335% Monday, while the five-year yield rose to 3.981% from 3.947%.The total market value of the cryptocurrency industry dropped 0.4% in the past 24 hours to $2.55 trillion, with trading volume dropping 0.5% to $155.16 billion.Price: $76342.31, Change: $-1025.97, Percent Change: -1.33%

$ADA-USD$BNB-USD$BTC-USD$DOGE-USD$ETH-USD$SOL-USD$XRP-USD

Wire104d ago

Market Chatter: US Closes Probe Into Claims Meta Can Access WhatsApp Messages

Meta Platforms (META) saw a US Commerce Department agency close an investigation into allegations it can access encrypted WhatsApp messages, Bloomberg News reported Tuesday, citing two people familiar with the matter.A department investigator told other federal officials earlier this year that, after a 10-month probe, he had concluded Meta stores and can view WhatsApp messages, the report said.Meta has strongly denied the allegations, saying WhatsApp's architecture secures encrypted conversations, the report said.Meta and the Commerce Department did not immediately respond to requests for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)Price: $671.45, Change: $-7.17, Percent Change: -1.06%

$META

Wire104d ago

Erasca Shares Fall After Preliminary Phase 1 Dose Escalation Data

Erasca (ERAS) shares fell 48% Tuesday after the company reported preliminary phase 1 dose-escalation data for its experimental ERAS-0015 in patients with RAS-mutant solid tumors, including colorectal cancer, non-small-cell lung cancer and pancreatic adenocarcinoma.The preliminary data, from ongoing trials in the US and China, suggest ERAS-0015 may be combined with standard-of-care doses of panitumumab, positioning it as a potential backbone therapy for future combination regimens, the company said.The therapy was generally "well tolerated," with no dose-limiting toxicities or treatment discontinuations due to adverse events, according to a statement.Erasca said it selected 24 mg and 32 mg once daily as recommended doses for further study and said the drug showed "promising clinical potential" for combination use with panitumumab.In a regulatory filing, the company said a patient, who was a 66 year-old male with heavily pretreated metastatic pancreatic adenocarcinoma, had died. The company said grade 3 treatment-related adverse events of pneumonitis progressed to grade 5 following withdrawal of supportive care per patient decision.Price: $9.96, Change: $-9.20, Percent Change: -48.02%

$ERAS

Wire104d ago

Boeing Gets Order for Up to 60 737 MAX Jets From Copa Airlines

Boeing (BA) said Tuesday it has secured an order for 40 of its 737 MAX airplanes from Copa Airlines, with options for up to 20 more aircraft.Financial details weren't provided.The Panamanian carrier aims to expand its fleet by more than 100 737 MAX aircraft to grow and modernize its network across the Americas and Caribbean, Boeing said.Price: $230.03, Change: $-1.30, Percent Change: -0.56%

$BA

Showing 8921-8940 of 10800